Registered entities
Meryx Inc.
Reg. No. 462774382United States
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Developing orally bioavailable cancer drugs targeting Mer Tyrosine kinase receptor.
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |